Home › Research › Clinical trials
Clinical trials
Every Alzheimer's trial in our copy of the ClinicalTrials.gov registry — completed, running and abandoned. Filter it, then follow the link to the official record.
If you are thinking about joining a trial
A listing here is a record that a study was registered. It is not a recommendation, and it does not mean the study is still recruiting or that anyone is eligible. Registry entries go stale.
Talk to the treating doctor first, then contact the study team listed on the official ClinicalTrials.gov record. The NIA's free referral line can help you look: 1-800-438-4380, weekdays, English and Spanish.
Showing 851–875 of 7,816 matching trials · page 35 of 313, 25 per page.
Sorted by the date the registry record was last updated, newest first. This page never loads all 7,816 rows at once — use the CSV download if you want the whole file.
| Trial | Phase | Status | Enrolled | Sponsor | Last updated |
|---|---|---|---|---|---|
|
VOCALE LBD: Online Peer Support for Caregivers of People With Lewy Body Dementia NCT07637097 VOCALE LBD: Virtual Online Communities for Aging Life Experiences: ... Runs in: United States · 1 site |
NA other |
NOT_YET_RECRUITING | 220 | University of Washington OTHER |
2026-06-09 |
|
Functional Magnetic Resonance Imaging - Synthetic Aperture Magnetometry (fMRI-SAM) and Alzheimer's Disease NCT00412048 fMRI to detect MCI patients who will convert to Alzheimer's disease |
NA other |
WITHDRAWN | 0 | University Hospital, Strasbourg, France OTHER |
2026-06-08 |
|
F 18 T807 Tau PET Imaging of Alzheimer's Disease NCT02414347 F 18 T807 Runs in: United States · 1 site |
NA other |
RECRUITING | 900 | Tammie L. S. Benzinger, MD, PhD OTHER |
2026-06-08 |
|
K0706 for Patients Diagnosed With Dementia With Lewy Bodies NCT03996460 Placebo; 192 mg powder of K0706; 384 mg powder of K0706 Runs in: United States · 1 site |
PHASE2 other |
TERMINATED | 29 | Georgetown University OTHER |
2026-06-08 |
|
Study of Tau Imaging With the Use of [18F]MK-6240 Tracer NCT04104659 MK 6240 Runs in: United States · 1 site |
NA other |
ENROLLING_BY_INVITATION | 200 | Tammie L. S. Benzinger, MD, PhD OTHER |
2026-06-08 |
|
Neuroimaging in Healthy Aging and Senile Dementia (HASD_IND) NCT04579120 [11C]-Pittsburgh Compound B ([11C]PiB); F 18 AV-1451 (Flortaucipir) Runs in: United States · 1 site |
NA other |
RECRUITING | 650 | Tammie L. S. Benzinger, MD, PhD OTHER |
2026-06-08 |
|
Manage Emotions to Reduce Aggression (MERA) NCT04793776 Manage Emotions to Reduce Aggression; Present Centered Psychotherapy Runs in: United States · 2 sites |
NA other |
RECRUITING | 204 | VA Office of Research and Development OTHER_GOV |
2026-06-08 |
|
Depression and Driving NCT05446805 F 18 AV-1451 (Flortaucipir); [11C]-Pittsburgh Compound B ([11C]PiB) Runs in: United States · 1 site |
NA other |
RECRUITING | 150 | Washington University School of Medicine OTHER |
2026-06-08 |
|
Silkworm Pupa Powder Improves Dementia. NCT06898476 Silkworm pupa powder; Placebo Runs in: China · 1 site |
NA other |
RECRUITING | 300 | Zhejiang Provincial Tongde Hospital OTHER |
2026-06-08 |
|
SUNAM Protocol for Managing BPSD NCT07041034 Active Comparator Group; Experimental Group Runs in: Taiwan · 2 sites |
NA other |
RECRUITING | 120 | Mackay Medical College OTHER |
2026-06-08 |
|
Biomarker-based Trial of NPC-1 for Alzheimer's Pathology NCT07236190 natural product combination-1 (NPC1) Runs in: United States · 1 site |
PHASE2 other |
RECRUITING | 40 | Massachusetts General Hospital OTHER |
2026-06-08 |
|
Study of Bedroom Environment Sleep Intervention at Home for Older Adults Living Alone With Memory Concerns NCT07440498 Bedroom Environment Tailoring; Sleep Health Education |
NA other |
NOT_YET_RECRUITING | 40 | Johns Hopkins University OTHER |
2026-06-08 |
|
LiO-AD: Lithium Orotate in Alzheimers Disease Feasibility, Biomarker Engagement, and Clinical Response NCT07459959 Lithium orotate; Matched Placebo (Capsules) |
PHASE1|PHASE2 other |
NOT_YET_RECRUITING | 40 | Johns Hopkins University OTHER |
2026-06-08 |
|
Assessment of Motor Reserve in the Preclinical Stages of Dementia NCT07634055 Sensor-based medical device for kinematic assessment: Hand Test Sys... Runs in: Italy · 1 site |
NA other |
RECRUITING | 200 | Istituto per la Ricerca e l'Innovazione Biomedica OTHER |
2026-06-08 |
|
Dance and Huntington Disease NCT01842919 Kinesthetics tests; Psychological questionnaires; structural Magnet... Runs in: France · 1 site |
NA other |
COMPLETED | 53 | Institut National de la Santé Et de la Recherche Médicale, France OTHER_GOV |
2026-06-05 |
|
Quantitative Evaluation of Apathy Close to Real Life Situation by Means of a Multimodal Sensor System Integrated. NCT02496312 Evaluation of Apathy Close to Real Life Situation Runs in: France · 1 site |
NA other |
COMPLETED | 14 | Institut National de la Santé Et de la Recherche Médicale, France OTHER_GOV |
2026-06-05 |
|
Study on the Health Economic Burden of Alzheimer's Disease in China NCT05995418 There was no intervention as this was an observational study. Runs in: China · 1 site |
NA other |
RECRUITING | 9,510 | Xuanwu Hospital, Beijing OTHER |
2026-06-05 |
|
Dementia With Lewy Bodies: Clinical Symptoms, Biomarkers and Progression NCT07629349 Runs in: Sweden · 1 site |
NA other |
RECRUITING | 600 | Karolinska Institutet OTHER |
2026-06-05 |
|
Validation and Reliability of the Turkish Version of the Montreal Cognitive Assessment-Basic (MoCA-B) in Individuals With Low Educational Level NCT07630688 Runs in: Turkey (Türkiye) · 1 site |
NA other |
COMPLETED | 166 | Antalya Training and Research Hospital OTHER_GOV |
2026-06-05 |
|
AHEAD 3-45 Study: A Study to Evaluate Efficacy and Safety of Treatment With Lecanemab in Participants With Preclinical Alzheimer's Disease and Elevated Amyloid and Also in Participants With Early Preclinical Alzheimer's Disease and Intermediate Amyloid NCT04468659 Lecanemab; Placebo Runs in: Australia; Canada; Japan; Singapore; Spain; United Kingdo... · 107 sites |
PHASE3 anti-amyloid-antibody |
ACTIVE_NOT_RECRUITING | 1,400 | Eisai Inc. INDUSTRY |
2026-06-04 |
|
Breathing, Relaxation, Attention Training, & Health in Older Adults (BREATHE) NCT04522791 RFB; VSOP; IR Runs in: United States · 1 site |
NA other |
COMPLETED | 113 | University of Rochester OTHER |
2026-06-04 |
|
Resilient Together for Dementia (RT-D) NCT06619327 Resilient Together for Dementia; MEUC Runs in: United States · 1 site |
NA other |
RECRUITING | 24 | Icahn School of Medicine at Mount Sinai OTHER |
2026-06-04 |
|
A Study of LY4006895 in Healthy Participants With Early Symptomatic Alzheimer's Disease (AD) NCT06657768 LY4006895; Placebo Runs in: Japan; United States · 13 sites |
PHASE1 other |
RECRUITING | 128 | Eli Lilly and Company INDUSTRY |
2026-06-04 |
|
Crownlands Observing Progression With Neurons Study NCT07611396 Runs in: United States · 1 site |
NA other |
RECRUITING | 160 | Crownlands INDUSTRY |
2026-06-04 |
|
Acupressure for Agitation, Pain, and Sleep in Mechanically Ventilated ICU Patients NCT07619326 Acupressure; Light Touch Runs in: Taiwan · 1 site |
NA other |
COMPLETED | 60 | Yang Yun Shiuan OTHER |
2026-06-04 |
This table is wider than a phone screen — swipe it sideways to see the rest.
Where these trials come from
- Registry
- ClinicalTrials.gov, pulled through their public API (v2)
- Trials in the file
- 7,816
- Source file
- trials.csv (3.8 MB, 7816 rows)
- Basis
- Measured These are registry records as submitted by each study's sponsor.
What could make this misleading
Sponsors enter their own data and do not always keep it current, so "recruiting" can be out of date by months or years. Enrollment figures may be targets rather than actual numbers; the downloaded file says which for each trial. Trials that were never registered do not appear at all, and the intervention class is this project's own grouping, not the registry's.
Always check the official record before acting on anything here. This is a summary, not medical advice.
From the research library
The highest-scoring studies we hold on this subject, each summarised in plain English. Scores are alzhub's usefulness score, not a verdict on the science.
Clinical trials
- MINocyclinE to Reduce inflammation and blood-brain barrier leakage in small Vessel diseAse (MINERVA): A phase II, randomized, double-blind, placebo-controlled experimental medicine trial
- Safety and efficacy of crenezumab in cognitively unimpaired carriers of the PSEN1Glu280Ala mutation at risk for autosomal-dominant Alzheimer's disease in Colombia (API ADAD Colombia Trial): a phase 2, randomised, double-blind, placebo-controlled trial
- Study of mirtazapine for agitated behaviours in dementia (SYMBAD): a randomised, double-blind, placebo-controlled trial
- Randomized, double-blind study of zervimesine in mild to moderate Alzheimer's disease
- Efficacy assessment of an active tau immunotherapy in Alzheimer's disease patients with amyloid and tau pathology: a post hoc analysis of the "ADAMANT" randomised, placebo-controlled, double-blind, multi-centre, phase 2 clinical trial